Co-Director, Sarcoma Program
Massachusetts General Hospital
Thomas F. DeLaney, M.D. is a graduate of Harvard College and Medical School. Following internship in General Surgery at Yale-New Haven Hospital, he trained in Radiation Oncology at the Massachusetts General Hospital (MGH) followed by 6 years as a Senior Investigator at the NCI. Since 1992, he has been on the staff/faculty at MGH and Harvard Medical School (HMS). Currently, he is Associate Medical Director of the Burr Proton Therapy Center at MGH, Co-Director of the Sarcoma Center at MGH, and Andres Soriano Professor of Radiation Oncology (HMS). He is a Fellow of the American Society for Radiation Oncology (ASTRO).
He has served on the Executive Board of the Connective Tissue Oncology Society and the NCCN Soft Tissue Sarcoma Guidelines Panel, and currently serves as a member of the Medical Advisory Board of the Chordoma Foundation. He leads the NRG Oncology Proton Clinical Trials Working Group and is an active member of the NRG Oncology Sarcoma Working Group.
Dr. DeLaney is active in sarcoma and proton radiation clinical research. He was the principal investigator of NCI-funded P01 and U19 proton therapy grants from 2005-2016. His curriculum vitae lists over 170 original reports as well as over 100 reviews, book chapters, editorials, and clinical guidelines. He co-edited the books, Proton and Charged Particle Radiotherapy (2007) and Sarcomas: Evidence-Based Diagnosis and Management (2020) . He has served on the editorial boards of the Journal of Surgical Oncology, Annals of Surgical Oncology, Journal of Clinical Oncology, and UpToDate in Oncology.
